HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"L 338/64
EN
Official Journal of the European Union
21.12.2011
COMMISSION IMPLEMENTING DECISION
of 19 December 2011
approving certain amended programmes for the eradication and monitoring of animal diseases and
zoonoses for the year 2011 and amending Decision 2010/712/EU as regards the financial
contribution by the Union for programmes approved by that Decision
(notified under document C(2011) 9478)
(2011/862/EU)
THE EUROPEAN COMMISSION,
(4) The
Commission
has
assessed
the
reports
submitted
by
the Member States on the expenditures incurred for those
programmes. The results of that assessment show that
certain Member States will not utilise their full allocation
Having regard to the Treaty on the Functioning of the European
for the year 2011 while others will spend in excess of
Union,
the allocated amount.
(5) Certain
Member
States
have
informed
the
Commission
Having regard to Council Decision 2009/470/EC of 25 May
that, under the current financial situation, additional
2009 on expenditure in the veterinary field ( 1 ), and in particular
support to the compensation of owners of culled
Articles 27(5) and (6) and 28(2) thereof,
animals and other measures financed at a level of 50 %
is required to ensure the continuity of the EU co-financed
veterinary programmes, in order to maintain the positive
trend regarding the different diseases.
Whereas:
(6) The
Commission
examined
the
requests
for
an
increased
level of funding taking into account the veterinary
(1) Decision
2009/470/EC
lays
down
the
procedures
situation and the availability of funds from the current
governing the financial contribution by the Union for
financial year, and considered appropriate that the
programmes for the eradication, control and monitoring
eligible measures financed at a level of 50 %, receive
of animal diseases and zoonoses.
reinforced support by modifying the level of funding to
60 %.
(2) Commission
Decision
2008/341/EC
of
25
April
2008
laying down Community criteria for national
(7) The
financial
contribution
by
the
Union
for
a
number
of
programmes for the eradication, control and monitoring
national programmes therefore needs to be adjusted. It is
of certain animal diseases and zoonoses (
appropriate to reallocate funding from national

2 ) provides that
in order to be approved under the measures provided for
programmes which will not use their full allocation to
in Article 27(1) of Decision 2009/470/EC, programmes
those that are expected to exceed it. The reallocation
submitted by the Member States to the Commission for
should be based on the most recent information on
the eradication, control and monitoring of the animal
expenditure actually incurred by the concerned Member
diseases and zoonoses listed in the Annex to that
States.
Decision must meet at least the criteria set out in the
Annex to Decision 2008/341/EC.
(8) In
addition,
Portugal
has
submitted
an
amended
programme for the eradication of bovine brucellosis,
Latvia has submitted an amended programme for the
(3) Commission
Decision
2010/712/EU
of
23
November
control of salmonellosis, Romania and Slovakia have
2010 approving annual and multiannual programmes
submitted amended programmes for the control and
and the financial contribution from the Union for the
monitoring of classical swine fever, Denmark has
eradication, control and monitoring of certain animal
submitted an amended survey programme for avian
diseases and zoonoses presented by the Member States
influenza in poultry and wild birds, Belgium, the Czech
for 2011 and following years
( 3 ) approves certain
Republic, Denmark, Germany, Estonia, Ireland, Spain,
national programmes and sets out the rate and
France, Italy, Cyprus, Latvia, Luxembourg, Hungary, the
maximum amount of the financial contribution by the
Netherlands, Austria, Poland, Portugal, Slovenia, Slovakia,
Union for each programme submitted by the Member
Finland, Sweden, and the United Kingdom have
States.
submitted amended programmes for transmissible spon
giform encephalopathies (TSE), bovine spongiform encep
halopathy (BSE) and scrapie and Romania, Slovenia and
( 1 ) OJ L 155, 18.6.2009, p. 30.
( 2 ) OJ L 115, 29.4.2008, p. 44.
Finland submitted amended programmes for the eradi
( 3 ) OJ L 309, 25.11.2010, p. 18.
cation of rabies.

---

EN
21.12.2011 Official
Journal
of
the
European
Union L
338/65
(9) The Commission has assessed those amended
Article 5
programmes from both the veterinary and the financial
point of view. They were found to comply with relevant
Approval of amended programmes for transmissible
Union veterinary legislation and in particular with the
spongiform encephalopathies (TSE), bovine spongiform
criteria set out in the Annex to Decision 2008/341/EC.
encephalopathy (BSE) and scrapie submitted by certain
The amended programmes should therefore be approved.
Member States
The following amended programmes for the monitoring of
(10) Decision
2010/712/EU should therefore be amended
transmissible spongiform encephalopathies (TSE), and for the
accordingly.
eradication of bovine spongiform encephalopathy (BSE) and of
scrapie are hereby approved for the period from 1 January
2011 to 31 December 2011:
(11) The
measures provided for in this Decision are in
accordance with the opinion of the Standing
Committee on the Food Chain and Animal Health,
(a) the programme submitted by Belgium on 15 June 2011;
HAS ADOPTED THIS DECISION:
(b) the programme submitted by the Czech Republic on
17 June 2011;
Article 1
Approval of amended programme for the eradication of
(c) the programme submitted by Denmark on 8 June 2011;
bovine brucellosis submitted by Portugal
The amended programme for bovine brucellosis submitted by
(d) the programme submitted by Germany on 14 June 2011;
Portugal on 12 April 2011 is hereby approved for the period
from 1 January 2011 to 31 December 2011.
(e) the programme submitted by Estonia on 27 June 2011;
Article 2
(f) the
programme
submitted
by
Ireland
on 29
June
2011;
Approval of amended programmes for salmonellosis
(zoonotic salmonella) in breeding, laying and broiler
flocks of Gallus gallus and in flocks of turkeys (Meleagris
(g) the programme submitted by Spain on 1 July 2011;
gallopavo) submitted by Belgium and Latvia
The following amended programmes for the control of certain
(h) the programme submitted by France on 13 July 2011;
zoonotic salmonella in breeding, laying and broiler flocks of
Gallus gallus and in flocks of turkeys (Meleagris gallopavo) are
(i) the
programme
submitted
by for
Italy
on 22 June
2011;
is hereby approved for the period from 1 January 2011 to
31 December 2011:
(j) the
programme
submitted
by
Cyprus
on
30
June
2011;
(a) the programme submitted by Belgium on 26 July 2011;
(k) the programme submitted by Latvia on 28 June 2011;
(b) the programme submitted by Latvia on 8 March 2011.
(l) the programme submitted by Luxembourg on 24 June
Article 3
2011;
Approval of amended programme for classical swine fever
programmes submitted by Romania and Slovakia
(m) the programme submitted by Hungary on 29 June 2011;
The following amended programmes for the control and moni
toring of classical swine fever are hereby approved for the
(n) the programme submitted by the Netherlands on 30 June
period from 1 January 2011 to 31 December 2011:
2011;
(a) the programme submitted by Romania on 7 October 2011;
(o) the programme submitted by Austria on 29 June 2011;
(b) the programme submitted by Slovakia on 21 November
(p) the programme submitted by Poland on 28 June 2011;
2011.
(q) the programme submitted by Portugal on 29 June 2011;
Article 4
Approval of amended survey programme for avian
(r) the programme submitted by Slovenia on 8 June 2011;
influenza in poultry and wild birds submitted by Denmark
The amended survey programme for avian influenza in poultry
(s) the programme submitted by Slovakia on 30 June 2011;
and wild birds submitted by Denmark on 4 March 2011 is
hereby approved for the period from 1 January 2011 to
31 December 2011.
(t) the programme submitted by Finland on 22 June 2011;

---

L 338/66
EN
Official Journal of the European Union
21.12.2011
(u) the programme submitted by Sweden on 20 June 2011;
(b) paragraph 2(c) is replaced by the following:
(v) the programme submitted by the United Kingdom on
‘(c) shall not exceed the following:
28 June 2011.
(i) EUR 16 000 000 for Ireland;
Article 6
(ii) EUR 18 500 000 for Spain;
Approval of amended programmes for rabies submitted by
Romania and Finland
(iii) EUR 5 500 000 for Italy;
The following amended programmes for rabies are hereby
(iv) EUR 1 440 000 for Portugal;
approved for the period from 1 January 2011 to
31 December 2011:
(v) EUR 26 500 000 for the United Kingdom.’;
(a) the programme submitted by Romania on 23 September
(c) in paragraph 3, points (a) and (b) are replaced by the
2011;
following:
(b) the programme submitted by Finland on 15 September
‘(a) for a tuberculin test:
EUR 2,4 per test;
2011.
(b) for a gamma-interferon EUR 6 per test’;
Article 7
test:
Approval of amended multiannual programme for rabies
3. Article 3 is amended as follows:
submitted by Slovenia
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
The amended multiannual programme for rabies submitted by
Slovenia on 16 September 2011 is hereby approved for the
(b) paragraph 2(c) is replaced by the following:
period from 1 January 2011 to 31 December 2012.
‘(c) shall not exceed the following:
Article 8
Amendments to Decision 2010/712/EU
(i) EUR 160 000 for Greece;
Decision 2010/712/EU is amended as follows:
(ii) EUR 9 200 000 for Spain;
1. Article 1 is amended as follows:
(iii) EUR 4 200 000 for Italy;
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(iv) EUR 85 000 for Cyprus;
(b) paragraph 2(c) is replaced by the following:
(v) EUR 2 260 000 for Portugal.’;
(c) in paragraph 3, points (a) and (b) are replaced by the
‘(c) shall not exceed the following:
following:
(i) EUR 4 600 000 for Spain;
‘(a) for a rose bengal test: EUR 0,24 per test;
(ii) EUR 3 000 000 for Italy;
(b) for a complement
EUR 0,48 per test;’;
fixation test:
(iii) EUR 90 000 for Cyprus;
4. Article 4 is amended as follows:
(iv) EUR 1 040 000 for Portugal;
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(v) EUR 1 350 000 for the United Kingdom.’;
(b) paragraph 2(c) is replaced by the following:
(c) in paragraph 3, points (a) to (d) are replaced by the
‘(c) shall not exceed the following:
following:
(i) EUR 420 000 for Belgium;
‘(a) for a rose bengal test: EUR 0,24 per test;
(ii) EUR 10 000 for Bulgaria;
(b) for a SAT test:
EUR 0,24 per test;
(iii) EUR 1 700 000 for the Czech Republic;
(c) for a complement
EUR 0,48 per test;
fixation test:
(iv) EUR 0 for Denmark;
(d) for an ELISA test:
EUR 1,2 per test’;
(v) EUR 400 000 for Germany;
2. Article 2 is amended as follows:
(vi) EUR 10 000 for Estonia;
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(vii) EUR 10 000 for Ireland;

---

EN
21.12.2011 Official
Journal
of
the
European
Union L
338/67
(viii) EUR 100 000 for Greece;
(ii) EUR 25 000 for Bulgaria;
(ix) EUR 5 200 000 for Spain;
(iii) EUR 2 100 000 for the Czech Republic;
(x) EUR 3 000 000 for France;
(iv) EUR 340 000 for Denmark;
(xi) EUR 300 000 for Italy;
(v) EUR 1 000 000 for Germany;
(xii) EUR 20 000 for Latvia;
(vi) EUR 40 000 for Estonia;
(xiii) EUR 5 000 for Lithuania;
(vii) EUR 120 000 for Ireland;
(xiv) EUR 60 000 for Hungary;
(viii) EUR 1 000 000 for Greece;
(xv) EUR 10 000 for Malta;
(ix) EUR 1 300 000 for Spain;
(xvi) EUR 50 000 for the Netherlands;
(x) EUR 660 000 for France;
(xvii) EUR 160 000 for Austria;
(xi) EUR 1 700 000 for Italy;
(xviii) EUR 50 000 for Poland;
(xii) EUR 150 000 for Cyprus;
(xix) EUR 1 650 000 for Portugal;
(xiii) EUR 1 650 000 for Latvia;
(xx) EUR 100 000 for Romania;
(xiv) EUR 20 000 for Luxembourg;
(xxi) EUR 50 000 for Slovenia;
(xv) EUR 2 400 000 for Hungary;
(xxii) EUR 60 000 for Slovakia;
(xvi) EUR 150 000 for Malta;
(xxiii) EUR 20 000 for Finland;
(xvii) EUR 3 900 000 for the Netherlands;
(xxiv) EUR 20 000 for Sweden.’;
(xviii) EUR 1 200 000 for Austria;
(c) in paragraph 3, points (a) to (f) are replaced by the
(xix) EUR 4 800 000 for Poland;
following:
(xx) EUR 65 000 for Portugal;
‘(a) for an ELISA test:
EUR 3 per test;
(b) for a PCR test:
EUR 12 per test;
(xxi) EUR 500 000 for Romania;
(c) for the purchase of
EUR 0,36 per dose;
(xxii) EUR 120 000 for Slovenia;
monovalent vaccines:
(xxiii) EUR 600 000 for Slovakia;
(d) for the purchase
EUR 0,54 per dose;
of bivalent vaccines:
(xxiv) EUR 75 000 for the United Kingdom.’;
(e) for the administration
EUR 1,80 per bovine
(c) in paragraph 3, points (a) to (e) are replaced by the
of vaccines to bovine
animal vaccinated,
following:
animals:
regardless of the
number and types of
‘(a) for a bacteriological
EUR 8,4 per test;
doses used;
test (cultivation/
(f) for the administration
EUR 0,90 per ovine or
isolation):
of vaccines to ovine
caprine animal
(b) for the purchase
EUR 0,06 per dose;
or caprine animals:
vaccinated, regardless of
of vaccine:
the number and types
of doses used.’;
(c) for serotyping of
EUR 24 per test;
relevant isolates of
5. Article 5 is amended as follows:
Salmonella spp.:
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(d) for a bacteriological
EUR 6 per test;
test to verify the
(b) paragraph 2(c) is replaced by the following:
efficiency of disinfection
of poultry houses
‘(c) shall not exceed the following:
after depopulation of
a salmonella-positive
(i) EUR 1 200 000 for Belgium;
flock:

---

L 338/68
EN
Official Journal of the European Union
21.12.2011
(e) for a test for the
EUR 6 per test.’;
(xvi) EUR 360 000 for Hungary
detection of
antimicrobials or
(xvii) EUR 20 000 for Malta;
bacterial growth
inhibitory effect in
(xviii) EUR 360 000 for the Netherlands;
tissues from birds
from flocks tested
(xix) EUR 60 000 for Austria;
for salmonella:
6. Article 6 is amended as follows:
(xx) EUR 100 000 for Poland;
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(xxi) EUR 45 000 for Portugal;
(b) paragraph 2(c) is replaced by the following:
(xxii) EUR 180 000 for Romania;
‘(c) shall not exceed the following:
(xxiii) EUR 50 000 for Slovenia;
(i) EUR 120 000 for Bulgaria;
(xxiv) EUR 15 000 for Slovakia;
(ii) EUR 1 600 000 for Germany;
(xxv) EUR 25 000 for Finland;
(iii) EUR 240 000 for France;
(xxvi) EUR 50 000 for Sweden;
(iv) EUR 160 000 for Italy;
(xxvii) EUR 160 000 for the United Kingdom.’;
(v) EUR 700 000 for Hungary;
(c) in paragraph 3, points (a) to (e) are replaced by the
(vi) EUR 700 000 for Romania;
following:
(vii) EUR 30 000 for Slovenia;
‘(a) ELISA test: EUR
2,4
per
test;
(b) agar gel immune
EUR 1,44 per test;
(viii) EUR 300 000 for Slovakia.’;
diffusion test:
(c) in paragraph 3, ‘EUR 2,5’ is replaced by ‘EUR 3’;
(c) HI test for H5/H7:
EUR 14,40 per test;
7. Article 8 is amended as follows:
(d) virus isolation test: EUR
48
per
test;
(a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’;
(e) PCR test:
EUR 24 per test.’;
(b) paragraph 2(c) is replaced by the following:
8. Article 9 is amended as follows:
‘(c) shall not exceed the following:
(a) in paragraph 2(c), ‘50 %’ is replaced by ‘60 %’;
(i) EUR 90 000 for Belgium;
(b) paragraph 2(d) is replaced by the following:
(ii) EUR 25 000 for Bulgaria;
‘(d) shall not exceed the following:
(iii) EUR 70 000 for the Czech Republic;
(i) EUR 1 900 000 for Belgium;
(iv) EUR 80 000 for Denmark;
(ii) EUR 330 000 for Bulgaria;
(v) EUR 300 000 for Germany;
(iii) EUR 1 030 000 for the Czech Republic;
(vi) EUR 10 000 for Estonia;
(iv) EUR 1 370 000 for Denmark;
(vii) EUR 75 000 for Ireland;
(v) EUR 7 750 000 for Germany;
(viii) EUR 50 000 for Greece;
(vi) EUR 330 000 for Estonia;
(ix) EUR 150 000 for Spain;
(vii) EUR 4 000 000 for Ireland;
(x) EUR 150 000 for France;
(xi) EUR 1 000 000 for Italy;
(viii) EUR 2 000 000 for Greece;
(xii) EUR 20 000 for Cyprus;
(ix) EUR 6 650 000 for Spain;
(xiii) EUR 45 000 for Latvia;
(x) EUR 18 850 000 for France;
(xiv) EUR 10 000 for Lithuania;
(xi) EUR 6 000 000 for Italy;
(xv) EUR 10 000 for Luxembourg;
(xii) EUR 1 700 000 for Cyprus;

---

EN
21.12.2011 Official
Journal
of
the
European
Union L
338/69
(xiii) EUR 320 000 for Latvia;
(d) in point (v) ‘EUR 5 000 000’ is replaced by
‘EUR 2 100 000’;
(xiv) EUR 720 000 for Lithuania;
(xv) EUR 125 000 for Luxembourg;
(e) in point (vii) ‘EUR 200 000’ is replaced by
‘EUR 290 000’;
(xvi) EUR 1 180 000 for Hungary;
10. in Article 10 paragraph 4, ‘paragraphs 2 and 3’ is replaced
(xvii) EUR 25 000 for Malta;
by ‘paragraph 2(a), paragraph 2(b) and paragraph 3’;
(xviii) EUR 3 530 000 for the Netherlands;
11. Article 11, paragraph 5(c) is amended as follows:
(xix) EUR 1 800 000 for Austria;
(a)
in point (i) ‘EUR
2
250
000’ is replaced by
(xx) EUR 3 440 000 for Poland;
‘EUR 1 600 000’;
(xxi) EUR 1 800 000 for Portugal;
(b) in point (ii) ‘EUR 1 800 000’ is replaced by
‘EUR 1 500 000’;
(xxii) EUR 1 000 000 for Romania;
(xxiii) EUR 250 000 for Slovenia;
(c)
in point (v) ‘EUR
740
000’ is replaced by
‘EUR 850 000’;
(xxiv) EUR 550 000 for Slovakia;
12. in Article 11 paragraph 7, ‘paragraphs 5 and 6’ is replaced
(xxv) EUR 580 000 for Finland;
by ‘paragraph 5(a), paragraph 5(b) and paragraph 6’.
(xxvi) EUR 850 000 for Sweden;
Article 9
(xxvii) EUR 6 500 000 for the United Kingdom.’;
Addressees
(c) in paragraph 3(d) ‘EUR 10’ is replaced by ‘EUR 12’;
This Decision is addressed to the Member States.
9. Article 10, paragraph 2(c) is amended as follows:
(a)
in point (i) ‘EUR
1
800
000’ is replaced by
‘EUR 850 000’;
Done at Brussels, 19 December 2011.
(b) in point (ii) ‘EUR 620 000’ is replaced by
‘EUR 570 000’;
For the Commission
(c) in point (iv) ‘EUR 7 110 000’ is replaced by
John DALLI
‘EUR 8 110 000’;
Member of the Commission

---